To help improve EGFR variant clinical testing and examine use of rapid variant testing methods in NSCLC, the FACILITATE (fast, accurate, IdyllaTM-based investigation of turnaround time in EGFR testing) study was performed. Here, EGFR is linked to non-small cell lung carcinoma.